Markets

Ohr Pharmaceutical (OHRP) in Focus: Stock Falls 8.4% - Tale of the Tape

Ohr Pharmaceutical, Inc. ( OHRP ) saw a big move last session, as the company's shares fell by over 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for OHRP, as the stock is now down over 27% since Jan 14, 2015.

This slump shouldn't be too much of a surprise to investors, as the pharmaceutical company has seen 1 negative revision in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

OHRP currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Investors interested in the medical industry may consider better-ranked stock like Biodel Inc. ( BIOD ), which carries a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

OHR PHARMACEUT (OHRP): Get Free Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NBSE

Other Topics

Investing Stocks